Literature DB >> 28391740

Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder.

Bassem I Yamout1, Shawkat Beaini2, Maya M Zeineddine1, Nabil Akkawi3.   

Abstract

We report two cases of neuromyelitis optica spectrum disorder (NMOSD) who were misdiagnosed as multiple sclerosis (MS) and developed catastrophic relapses following initiation of dimethyl fumarate. Both patients developed a severe myelitis extending from the cervical cord to the medulla with significant cord swelling, resulting in complete quadriplegia and respiratory difficulties, in addition to severe bilateral visual loss in one patient. It is of note that both catastrophic relapses occurred 2 and 3 months following initiation of dimethyl fumarate.

Entities:  

Keywords:  Neuromyelitis optica; aquaporin 4; dimethyl fumarate

Mesh:

Substances:

Year:  2017        PMID: 28391740     DOI: 10.1177/1352458517694086

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

Review 1.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

Review 2.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

3.  Acute Management of Optic Neuritis: An Evolving Paradigm.

Authors:  Lindsay Horton; Jeffrey L Bennett
Journal:  J Neuroophthalmol       Date:  2018-09       Impact factor: 3.042

Review 4.  Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.

Authors:  Jan Traub; Silke Häusser-Kinzel; Martin S Weber
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 5.  Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Authors:  Nadja Borisow; Masahiro Mori; Satoshi Kuwabara; Michael Scheel; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-23       Impact factor: 4.003

6.  Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment.

Authors:  Keita Takahashi; Hideyuki Takeuchi; Ryoko Fukai; Haruko Nakamura; Keisuke Morihara; Yuichi Higashiyama; Toshiyuki Takahashi; Hiroshi Doi; Fumiaki Tanaka
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

7.  Case Report: Clinical and Imaging Characteristics of a Patient with Anti-flotillin Autoantibodies: Neuromyelitis Optica or Multiple Sclerosis?

Authors:  Ke Shang; Chang Cheng; Chuan Qin; Jun Xiao; Gang Deng; Bi-Tao Bu; Sha-Bei Xu; Dai-Shi Tian
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

Review 8.  Pediatric Neuromyelitis Optica Spectrum Disorders.

Authors:  Grace Y Gombolay; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2018-05-02       Impact factor: 3.972

9.  Dimethyl fumarate mitigates optic neuritis.

Authors:  Katarzyna Zyla; Chelsea M Larabee; Constantin Georgescu; Chelsea Berkley; Tania Reyna; Scott M Plafker
Journal:  Mol Vis       Date:  2019-08-22       Impact factor: 2.367

10.  Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling.

Authors:  Tianrong Yeo; Fay Probert; Maciej Jurynczyk; Megan Sealey; Ana Cavey; Timothy D W Claridge; Mark Woodhall; Patrick Waters; Maria Isabel Leite; Daniel C Anthony; Jacqueline Palace
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-10-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.